TG Therapeutics Announces FDA Approval of BRIUMVI™ (Ublituximab-xiiy)
Summary:- BRIUMVI is the first and only anti-CD20 monoclonal antibody approved for patients with relapsing forms of multiple sclerosis that can be…
Summary:- BRIUMVI is the first and only anti-CD20 monoclonal antibody approved for patients with relapsing forms of multiple sclerosis that can be…
Highlights: Terlivaz is the first and only FDA-approved treatment for adults with HRS involving rapid reduction in kidney function. Terlivaz is expected…
Synopsis : Takeda Pharmaceutical Company Limited, a global values-based, R&D-driven biopharmaceutical leader, announced the appointment of Serina Fischer as its General Manager…
Summary : hC Bioscience, Inc., a company focused on discovering and developing tRNA-based therapies, announced that it has raised $24 million in…
Summary : Takeda Pharmaceuticals was the top Future of Work innovator in the pharmaceutical sector in the last quarter. Research and innovation…
Summary- Five year follow-up data show FOTIVDA® (tivozanib) patients up to 5X more likely to experience long-term PFS compared to Nexavar® (sorafenib)…
Synopsis : Today, the U.S. Food and Drug Administration approved Nexviazyme (avalglucosidase alfa-ngpt) for intravenous infusion to treat patients 1 year of…
Summary : Vigabatrin is used to treat babies, one month to two years old with infantile spasms. Zydus has received final approval…
Summary : The drug, to be available under the brand name Quviviq, was approved in doses of 25 mg and 50 mg…
Blueprint Medicines Corporation a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced that, effective on…